Safe and Successful Surgical Outcome in Persons with Hemophilia A with and without Inhibitors Treated with Emicizumab: A Large, Single Center, Real-World Experience.

Castaman, Giancarlo; Linari, Silvia; Pieri, Lisa; Carulli, Christian; Prosperi, Paolo; Tonelli, Paolo; Demartis, Francesco; Fjerza, Rajmonda; Attanasio, Monica; Coppo, Mirella; Salvianti, Francesca

Castaman, Giancarlo; Linari, Silvia; Pieri, Lisa; Carulli, Christian; Prosperi, Paolo; Tonelli, Paolo; Demartis, Francesco; Fjerza, Rajmonda; Attanasio, Monica; Coppo, Mirella; Salvianti, Francesca.

Afiliación

Castaman G; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.
Linari S; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.
Pieri L; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.
Carulli C; Department of Orthopedic Surgery, University Hospital of Florence, 50139 Florence, Italy.
Prosperi P; Emergency Surgery Department, Careggi University Hospital, 50134 Florence, Italy.
Tonelli P; Department of Surgery and Translational Medicine, University of Florence, 50121 Florence, Italy.
Demartis F; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.
Fjerza R; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.
Attanasio M; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.
Coppo M; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.
Salvianti F; Center for Bleeding Disorders and Coagulation, Department of Oncology, Careggi University Hospital, 50134 Florence, Italy.

J Clin Med ; 12(6)2023 Mar 16.

Article en En | MEDLINE | ID: mdl-36983317

Palabras clave

FVIII concentrates; FVIII inhibitors; aPCC; hemophilia A; prophylaxis; recombinant FVIIa

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: J Clin Med Año: 2023 Tipo del documento: Article País de afiliación: Italia